Relationship of Laser-Doppler-Flow and coronary perfusion and a concise update on the importance of coronary microcirculation in donor heart machine perfusion
Restricted accessResearch articleFirst published online October 6, 2021
Relationship of Laser-Doppler-Flow and coronary perfusion and a concise update on the importance of coronary microcirculation in donor heart machine perfusion
Machine perfusion (MP) is a novel method for donor heart preservation. The coronary microvascular function is important for the transplantation outcome. However, current research on MP in heart transplantation focuses mainly on contractile function.
OBJECTIVE:
We aim to present the application of Laser-Doppler-Flowmetry to investigate coronary microvascular function during MP. Furthermore, we will discuss the importance of microcirculation monitoring for perfusion-associated studies in HTx research.
METHODS:
Porcine hearts were cardioplegically arrested and harvested (Control group, N = 4). In an ischemia group (N = 5), we induced global ischemia of the animal by the termination of mechanical ventilation before harvesting. All hearts were mounted on an MP system for blood perfusion. After 90 minutes, we evaluated the effect of coronary perfusion pressures from 20 to 100 mmHg while coronary laser-doppler-flow (LDF) was measured.
RESULTS:
Ischemic hearts showed a significantly decreased relative LDF compared to control hearts (1.07±0.06 vs. 1.47±0.15; p = 0.034). In the control group, the coronary flow was significantly lower at 100 mmHg of perfusion pressure than in the ischemia group (895±66 ml vs. 1112±32 ml; p = 0.016).
CONCLUSIONS:
Laser-Doppler-Flowmetry is able to reveal coronary microvascular dysfunction during machine perfusion of hearts and is therefore of substantial interest for perfusion-associated research in heart transplantation.
ArdehaliA, EsmailianF, DengM, SolteszE, HsichE, NakaY, et al. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial. Lancet. 2019;385(9987)::2577–84.
2.
RojasSV, IusF, SchibilskyD, KaufeldT, SommerW, BenkC, et al. Cardiac Transplantation in Higher Risk Patients: Is Ex Vivo Heart Perfusion a Safe Preservation Technique? A Two Center Experience. The Journal of Heart and Lung Transplantation. 2019;38(4):S43.
3.
SchroderJN, D’AlessandroD, EsmailianF, BoeveT, TangP, LiaoK, et al. Successful Utilization of Extended Criteria Donor (ECD) Hearts for Transplantation - Results of the OCS™ Heart EXPAND Trial to Evaluate the Effectiveness and Safety of the OCS Heart System to Preserve and Assess ECD Hearts for Transplantation. The Journal of Heart and Lung Transplantation. 2019;38(4):S42.
4.
SaemannL, GuoY, DingQ, ZhouP, KarckM, SzabóG, et al. Machine perfusion of circulatory determined death hearts: A scoping review. Transplant Rev (Orlando). 2020;34(3):100551.
5.
ParkJW, MatschkeK, MrowietzC, Krüger-GengeA, JungF. HELP-(Heparin-induced Extracorporeal LDL Precipitation)-apheresis in heart recipients with cardiac allograft vasculopathy and concomitant hypercholesterolemia: Influence of long-term treatment on the microcirculation. Clin Hemorheol Microcirc. 2019;73(1):19–27.
6.
HaddadF, KhazanieP, DeuseT, WeisshaarD, ZhouJ, NamCW, et al. , Clinical and functional correlates of early microvascular dysfunction after heart transplantation. Circ Heart Fail. 2012;5(6):759–68.
7.
MrowietzC, FrankeRP, PindurG, SternitzkyR, JungF, WolfU. Evaluation of Laser-Doppler-Fluxmetry for the diagnosis of microcirculatory disorders. Clin Hemorheol Microcirc. 2019;71(2):129–35.
8.
LeahyMJ, Mul deFF, NilssonGE, ManiewskiR. Principles and practice of the laser-Doppler perfusion technique. Technol Health Care. 1999;7(2-3):143–62.
9.
Institute of Laboratory Animal Resources; National Research Council. Guide for the care and use of laboratory animals. 6. print. Washington, D.C.: National Academy Press; 1996.
BaylissWM. On the local reactions of the arterial wall to changes of internal pressure. J Physiol. 1902;28(3):220–31.
12.
DickGM, NamaniR, PatelB, KassabGS. Role of Coronary Myogenic Response in Pressure-Flow Autoregulation in Swine: A Meta-Analysis With Coronary Flow Modeling. Front Physiol. 2018;9:580.
13.
DignanRJ, KadletzM, DykeCM, LutzHA, YehT, WechslerAS. Microvascular dysfunction after myocardial ischemia. The Journal of Thoracic and Cardiovascular Surgery. 1995;109(5):892–8.
VeresG, RadovitsT, MerkelyB, KarckM, SzabóG. Custodiol-N, the novel cardioplegic solution reduces ischemia/reperfusion injury after cardiopulmonary bypass. J Cardiothorac Surg. 2015;10:27.
16.
RibeiroRVP, AlvarezJS, YuF, ParadisoE, AdamsonMB, Maria RuggeriG, et al. Hearts Donated After Circulatory Death and Reconditioned Using Normothermic Regional Perfusion Can Be Successfully Transplanted Following an Extended Period of Static Storage. Circ Heart Fail. 2019;12(4):e005364.
17.
ZhouP, LiuX, XiaoZ, XuR, LinX, ZhuP, et al. Machine perfusion of donor heart with normothermic blood versus hypothermic HTK in preserving coronary endothelium in a porcine model of DCD. Ann Palliat Med. 2020;9(4):1476–87.
18.
SaemannL, WenzelF, KohlM, Korkmaz-IcözS, HoornF, LoganathanS, et al. Monitoring of perfusion quality and prediction of donor heart function during ex-vivo machine perfusion by myocardial microcirculation versus surrogate parameters. J Heart Lung Transplant. 2021;40(5):387–91.
19.
KawataT, DaimonM, MiyazakiS, IchikawaR, MaruyamaM, ChiangS-J, et al. Coronary microvascular function is independently associated with left ventricular filling pressure in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2015;14:98.
20.
SaemannL, Korkmaz-IcözS, HoornF, VeresG, KraftP, GeorgeviciA-I, et al. Reconditioning of circulatory death hearts by ex-vivo machine perfusion with a novel HTK-N preservation solution. The Journal of Heart and Lung Transplantation 2021.
21.
WhiteCW, MesserSJ, LargeSR, ConwayJ, KimDH, KutsogiannisDJ, et al. Transplantation of Hearts Donated after Circulatory Death. Front Cardiovasc Med. 2018;5:8.
22.
MesserS, CernicS, PageA, BermanM, KaulP, ColahS, et al. A 5-year single-center early experience of heart transplantation from donation after circulatory-determined death donors. J Heart Lung Transplant. 2020;39(12):1463–75.
23.
BillinghamME, BaumgartnerWA, WatsonDC, ReitzBA, MasekMA, RaneyAA, et al. Distant heart procurement for human transplantation. Ultrastructural studies. Circulation. 1980;62(2 Pt 2):I11–9.
24.
YamaniMH, HajiSA, StarlingRC, TuzcuE, RatliffNB, CookDJ, et al. Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome. Journal of the American College of Cardiology. 2002;39(6):970–7.
25.
SyrjäläSO, NykänenAI, TuuminenR, RaissadatiA, KeränenMAI, ArnaudovaR, et al. Donor Heart Treatment With COMP-Ang1 Limits Ischemia-Reperfusion Injury and Rejection of Cardiac Allografts. Am J Transplant. 2015;15(8):2075–84.
26.
PernowJ. The role of the endothelium for reperfusion injury. European Heart Journal Supplements. 2001;3:C22–C27.
27.
YangQ, HeG-W, UnderwoodMJ, YuC-M. Cellular and molecular mechanisms of endothelial ischemia/reperfusion injury: perspectives and implications for postischemic myocardial protection. Am J Transl Res. 2016;8(2):765–77.
28.
KangCH, AnrakuM, CypelM, SatoM, YeungJ, GharibSA, et al. Transcriptional signatures in donor lungs from donation after cardiac death vs after brain death: a functional pathway analysis. J Heart Lung Transplant. 2011;30(3):289–98.
